BP000059-CYT-545: Recombinant Human B cell Activating Factor (BAFF), His Tag Protein
Source: E. Coli-derived.
Purity: > 95% by RP-HPLC and SDS-PAGE.C001P: Bevacizumab Biosimilar, Human VEGF Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody generated from the same parent mouse antibody as ranibizumab.
Specificity/Sensitivity: The monoclonal antibody bevacizumab biosimilar specifically binds to the human VEGF-A.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by bevacizumab.BP005690: Biotinylated Cynomolgus BAFF/TNFSF13B/CD257 Trimer Protein with the N-His-Avi-Flag Tag
Source: The recombinant Biotinylated Cynomolgus BAFF/TNFSF13B/CD257 Trimer Protein, (amino acids Thr141-Leu285) fused with a His-Avi-Flag tag at the N-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Biotinylated Cynomolgus BAFF (Trimer) protein with the N-His-Avi-Flag tag at 5 ug/ml (100 ul/well) on the streptavidin precoated plate (5 ug/ml). Dose response curve for the recombinant Human BAFFR protein with the N-hFc tag with the EC50 of 55.3 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP005078: Biotinylated Human IL-2 R alpha/CD25 Protein with the C-His-Avi Tag
Source: The recombinant Biotinylated Human IL-2 R alpha/CD25 Protein, (amino acids Glu22-Cys213) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Anti-CD25 Antibody protein with the C-His-Avi tag at 0.2 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Biotinylated Human IL-2 R alpha protein with the C-His tag with the EC50 of 11.9 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.C002P: Cetuximab Biosimilar, Human EGFR Monoclonal Antibody
Recombinant Chimeric IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The monoclonal antibody cetuximab biosimilar specifically binds to the human EGFR.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by cetuximab.BP004894: Cynomolgus APRIL/TNFSF13 Trimer Protein with the N-His-Avi-Flag Tag
Source: The recombinant Cynomolgus APRIL/TNFSF13 Trimer Protein, (amino acids Lys112-Leu250) fused with a His-Avi-Flag tag at the N-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Cynomolgus APRIL (Trimer) protein with the N-His-Avi-Flag tag at 1 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Cynomolgus BCMA protein with the N-hFc tag with the EC50 of 5.7 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP005061: Cynomolgus BAFF/TNFSF13B/CD257 Trimer Protein with the N-His-Avi Tag
Source: The recombinant Cynomolgus BAFF/TNFSF13B/CD257 Trimer Protein, (amino acids Thr141-Leu285) fused with a His-Avi tag at the N-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Cynomolgus BAFF Trimer protein with the N-His-Avi tag at 1 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Human BAFFR protein with the N-hFc tag with the EC50 of 0.26 ug/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.C043P: Daclizumab Biosimilar, CD25 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade daclizumab biosimilar specifically binds to the human interleukin-2 receptor (anti-Tac or anti-CD25).
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by daclizumab.C004P: Denosumab Biosimilar, Human RANKL Monoclonal Antibody
Recombinant Humanized IgG2 Monoclonal Antibody.
Specificity/Sensitivity: The monoclonal antibody denosumab biosimilar specifically binds to the human RANKL (RANK ligand) protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by denosumab.C104P: Dupilumab Biosimilar, IL4R alpha Monoclonal Antibody
Recombinant fully human IgG4 monoclonal antibody.
Specificity/Sensitivity: The monoclonal antibody dupilumab biosimilar specifically binds to the human IL4R alpha.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by dupilumab.